-
公开(公告)号:PT1395583E
公开(公告)日:2005-06-30
申请号:PT02722107
申请日:2002-02-19
Applicant: SOLVAY PHARM BV
Inventor: RONKEN ERIC , SCHARRENBURG GUSTAAF J M VAN , MCCREARY ANDREW C , FEENSTRA ROELOF W , KRUSE CORNELIS G
IPC: A61K31/496 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D413/12 , C07D471/06
Abstract: The invention relates to novel phenylpiperazine derivatives of the formula wherein: -R represents the group (a) or (b) as indicated in the description. These compounds are (partial) D2 receptor agonists and are usefull for treating CNS disorders, in particular Parkinson's disease.
-
公开(公告)号:HK1070646A1
公开(公告)日:2005-06-24
申请号:HK05103186
申请日:2005-04-14
Applicant: SOLVAY PHARM BV
Inventor: FEENSTRA ROELOF W , JM JOSEPHUS H LANGE , MARIA L PRAS-RAVES M , KRUSE CORNELIS G , STUIVENBERG HERMAN H VAN , TUINSTRA TINKA , KEIZER HISKIAS G
IPC: A61K20100101 , A61K31/415 , A61P20100101 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D20100101 , C07D231/04 , C07D401/04
Abstract: The invention relates to a group of novel 2,3 diaryl-pyparazolidine derivatives having formula (1). The symbols used in formula (1) have the meanings given in the specification. The compounds have inhibiting activity on enzymes which degrade the neuropeptide neurotensin and can be used for the treatment of affections and diseases caused by disturbances of the neurotensin mediated transmission.
-
23.
公开(公告)号:PL370632A1
公开(公告)日:2005-05-30
申请号:PL37063203
申请日:2003-02-11
Applicant: SOLVAY PHARM BV
Inventor: BRONZOVA JULIANA B , FEENSTRA ROELOF W , GLENNON JEFFREY C , MCCREARY ANDREW C , VAN RANDEN JAN , RONKEN ERIC , VAN SCHARRENBURG GUSTAAF
IPC: A61K45/00 , A61K31/00 , A61K31/138 , A61K31/445 , A61K31/48 , A61K31/495 , A61K31/535 , A61K31/55 , A61K45/06 , A61P25/00 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P43/00
Abstract: The invention relates to the use of a compound or a combination of compounds having partial dopamine-D2 receptor agonistic activity and serotonin and/or noradrenaline reuptake inhibitory activity, for the preparation of a pharmaceutical composition for the treatment of psychiatric and/or neurologic disorders caused by disturbances of the major monoaminergic (dopamine, serotonin and/or nordrenaline) systems or that can be treated via manipulation of those systems.
-
24.
公开(公告)号:HRP20040276A2
公开(公告)日:2005-04-30
申请号:HRP20040276
申请日:2004-03-19
Applicant: SOLVAY PHARM BV
Inventor: BRONZOVA JULIANA B , FEENSTRA ROELOF W , GLENNON JEFFREY C , MCCREARY ANDREW C , RANDEN JAN VAN , RONKEN ERIC , SCHARRENBURG GUUSTAAF J M VAN
IPC: A61K45/00 , A61K31/00 , A61K31/138 , A61K31/445 , A61K31/48 , A61K31/495 , A61K31/535 , A61K31/55 , A61K45/06 , A61P25/00 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P43/00
Abstract: The invention relates to the use of a compound or a combination of compounds having partial dopamine-D2 receptor agonistic activity and serotonin and/or noradrenaline reuptake inhibitory activity, for the preparation of a pharmaceutical composition for the treatment of psychiatric and/or neurologic disorders caused by disturbances of the major monoaminergic (dopamine, serotonin and/or nordrenaline) systems or that can be treated via manipulation of those systems.
-
公开(公告)号:NZ523135A
公开(公告)日:2005-02-25
申请号:NZ52313502
申请日:2002-02-19
Applicant: SOLVAY PHARM BV
Inventor: FEENSTRA ROELOF W , RONKEN ERIC , KRUSE CORNELIS G , MCCREARY ANDREW C , VAN SCHARRENBURG GUSTAAF J M
IPC: A61K31/496 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D413/12 , C07D471/06
Abstract: Phenylpiperazine derivatives of the formula (I) and their salts that show high affinity for both the dopamine D2 receptor and the serotonin reuptake site, that are active in therapeutic models sensitive to clinically relevant antipsychotics and that can be used for the treatment of affections or diseases of the central nervous system caused by disturbances in either the dopaminergic or serotonergic systems, for example: aggression, anxiety disorders, autism, vertigo, depression, disturbances of cognition or memory, Parkinson's disease and in schizophrenia and other psychotic disorders are disclosed, wherein: R is a group of the formula (a) or (b).
-
26.
公开(公告)号:AR038967A1
公开(公告)日:2005-02-02
申请号:ARP030100880
申请日:2003-03-13
Applicant: SOLVAY PHARM BV
Inventor: FEENSTRA ROELOF W , LANGE JOSEPHUS H M , PRAS-RAVES MARIA L , KRUSE CORNELIS G , VAN STUIVENBERG HERMAN H , KEISER HISKIAS G , TUINSTRA TINKA
IPC: A61K31/415 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D231/04 , C07D401/04
Abstract: Se refiere a un grupo de novedosos derivados de 2,3-diaril-pirazolidinas, procedimiento, composición farmacéutica y usos. Los compuestos tienen actividad inhibitoria de las enzimas que degradan el neuropéptido neurotensina y pueden ser utilizados para el tratamiento de afecciones y enfermedades causadas por perturbaciones de la transmisión mediada por neurotensina, como psicosis, Parkinson, depresión y ansiedad. Reivindicación 1: Derivados de 2,3-diaril-pirazolidina, caracterizados porque son de la fórmula (1) en donde: S1 es H, halógeno, hidroxi o alcoxi C1-3, S2 es H, o halógeno, S3 es H, halógeno, hidroxi o alcoxi C1-3; S4 es H, halógeno o alquilo C1-6 opcionalmente sustituido con hidroxi, alcoxi C1-3, amino, mono o dialquilamino que tiene 1-3 átomos de C en el(los) grupo(s) alquilo, SH o S-alquilo C1-3; X representa N o C; Y representa N u O cuando X es N, o Y es N cuando X es C; R3 y R4 son H o alquilo C1-3 independientemente uno de otro, R5 es H, o alquilo C1-6 el cual puede estar sustituido con halógeno, CN, CF3, hidroxi, alcoxi C1-3, sulfonilalquil C1-3, amino, mono- o dialquilamino que tiene 1-3 átomos de C en el(los) grupos alquilo cuando X es C o N, o R5 representa alcoxi C1-6, SH o S-alquilo C1-3, cuando X es C. R´5 es H o alquilo C1-3, R6 es H o alquilo C1-3, R7 es H o alquilo C1-3, R5 y R6 juntos o R´5 y R6 juntos pueden formar un grupo cíclico de 3-7 miembros el cual puede estar sustituido con un alquilo inferior, halógeno, CN, o CF3 y R5 + R´5 juntos pueden formar un anillo de 3-7 miembros, y Z1, Z2 y Z3 representan C, o Z1 es nitrógeno y Z2 y Z3 son C, o Z1 y Z3 son C y Z2 es nitrógeno, o Z1 y Z2 son C y Z3 es N, A es un sistema (poli) cicloalquilo que consiste de anillos de 4-10 miembros el cual puede estar sustituido con halógeno, CF3, alquilo o alcoxi C1-3, CN, OH SH, y sales farmacológicamente aceptables de los mismos.
-
公开(公告)号:BR0306149A
公开(公告)日:2004-10-19
申请号:BR0306149
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: FEENSTRA ROELOF W , LANGE JOSEPHUS H M , PRAS-RAVES MARIA L , KRUSE CORNELIS G , STUIVENBERG HERMAN H VAN , TUINSTRA TINKA , KEIZER HISKIAS G
IPC: A61K31/415 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D231/04 , C07D401/04
Abstract: The invention relates to a group of novel 2,3 diaryl-pyparazolidine derivatives having formula (1). The symbols used in formula (1) have the meanings given in the specification. The compounds have inhibiting activity on enzymes which degrade the neuropeptide neurotensin and can be used for the treatment of affections and diseases caused by disturbances of the neurotensin mediated transmission.
-
公开(公告)号:NO20044405L
公开(公告)日:2004-10-15
申请号:NO20044405
申请日:2004-10-15
Applicant: SOLVAY PHARM BV
Inventor: STUIVENBERG HERMAN HEINRICH VAN , FEENSTRA ROELOF W , KRUSE CORNELIS GERRIT , LANGE JOSEPHUS H M , PRAS-RAVES MARIA L
IPC: C07D231/04 , A61K31/415 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P43/00 , C07D401/04
Abstract: The invention relates to a group of novel 2,3 diaryl-pyparazolidine derivatives having formula (1). The symbols used in formula (1) have the meanings given in the specification. The compounds have inhibiting activity on enzymes which degrade the neuropeptide neurotensin and can be used for the treatment of affections and diseases caused by disturbances of the neurotensin mediated transmission.
-
公开(公告)号:ES2211809T3
公开(公告)日:2004-07-16
申请号:ES01938214
申请日:2001-05-10
Applicant: SOLVAY PHARM BV
Inventor: FEENSTRA ROELOF W , VAN DER HEIJDEN JOHANNES A M , KRUSE CORNELIS G , LONG STEPHEN K , VAN SCHARRENBURG GUSTAAF J M
IPC: C07D413/10 , A61K31/423 , A61K31/428 , A61K31/4439 , A61K31/445 , A61K31/4523 , A61K31/496 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/30 , A61P43/00 , C07D263/54 , C07D263/58 , C07D277/62 , C07D413/04 , C07D413/12 , C07D413/14
-
公开(公告)号:DK1283838T3
公开(公告)日:2004-03-22
申请号:DK01938214
申请日:2001-05-10
Applicant: SOLVAY PHARM BV
Inventor: LONG STEPHEN K , FEENSTRA ROELOF W , VAN DER HEIJDEN JOHANNES A M , KRUSE CORNELIS G , VAN SCHARRENBURG GUSTAAF J M
IPC: C07D413/10 , A61K31/423 , A61K31/428 , A61K31/4439 , A61K31/445 , A61K31/4523 , A61K31/496 , A61P25/00 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/30 , A61P43/00 , C07D263/54 , C07D263/58 , C07D277/62 , C07D413/04 , C07D413/12 , C07D413/14
-
-
-
-
-
-
-
-
-